vs
BYLINE BANCORP, INC.（BY）与Cytek Biosciences, Inc.（CTKB）财务数据对比。点击上方公司名可切换其他公司
BYLINE BANCORP, INC.的季度营收约是Cytek Biosciences, Inc.的1.8倍（$112.4M vs $62.1M），BYLINE BANCORP, INC.净利率更高（33.4% vs -70.9%，领先104.4%），BYLINE BANCORP, INC.同比增速更快（9.0% vs 8.1%），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs 6.4%）
Byline Bank是总部位于美国伊利诺伊州芝加哥的银行，为银行控股公司Byline Bancorp, Inc.的核心子公司，同时是全美SBA 7(a)贷款项目的第四大放贷机构，为客户提供专业的银行及融资相关服务。
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
BY vs CTKB — 直观对比
营收规模更大
BY
是对方的1.8倍
$62.1M
营收增速更快
BY
高出0.9%
8.1%
净利率更高
BY
高出104.4%
-70.9%
两年增速更快
CTKB
近两年复合增速
6.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $112.4M | $62.1M |
| 净利润 | $37.6M | $-44.1M |
| 毛利率 | — | 52.9% |
| 营业利润率 | — | -9.0% |
| 净利率 | 33.4% | -70.9% |
| 营收同比 | 9.0% | 8.1% |
| 净利润同比 | 33.0% | -557.1% |
| 每股收益（稀释后） | $0.83 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BYCTKB
| Q1 26 | $112.4M | — | ||
| Q4 25 | $117.0M | $62.1M | ||
| Q3 25 | $115.7M | $52.3M | ||
| Q2 25 | $110.5M | $45.6M | ||
| Q1 25 | $103.1M | $41.5M | ||
| Q4 24 | $104.7M | $57.5M | ||
| Q3 24 | $101.8M | $51.5M | ||
| Q2 24 | $99.4M | $46.6M |
净利润BYCTKB
| Q1 26 | $37.6M | — | ||
| Q4 25 | $34.5M | $-44.1M | ||
| Q3 25 | $37.2M | $-5.5M | ||
| Q2 25 | $30.1M | $-5.6M | ||
| Q1 25 | $28.2M | $-11.4M | ||
| Q4 24 | $30.3M | $9.6M | ||
| Q3 24 | $30.3M | $941.0K | ||
| Q2 24 | $29.7M | $-10.4M |
毛利率BYCTKB
| Q1 26 | — | — | ||
| Q4 25 | — | 52.9% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 54.6% |
营业利润率BYCTKB
| Q1 26 | — | — | ||
| Q4 25 | 40.1% | -9.0% | ||
| Q3 25 | 43.1% | -17.6% | ||
| Q2 25 | 35.2% | -23.3% | ||
| Q1 25 | 36.4% | -36.1% | ||
| Q4 24 | 38.6% | 5.2% | ||
| Q3 24 | 39.3% | -8.2% | ||
| Q2 24 | 40.4% | -18.3% |
净利率BYCTKB
| Q1 26 | 33.4% | — | ||
| Q4 25 | 34.1% | -70.9% | ||
| Q3 25 | 32.1% | -10.5% | ||
| Q2 25 | 27.2% | -12.2% | ||
| Q1 25 | 27.4% | -27.5% | ||
| Q4 24 | 34.3% | 16.8% | ||
| Q3 24 | 29.8% | 1.8% | ||
| Q2 24 | 29.9% | -22.4% |
每股收益（稀释后）BYCTKB
| Q1 26 | $0.83 | — | ||
| Q4 25 | $0.77 | — | ||
| Q3 25 | $0.82 | — | ||
| Q2 25 | $0.66 | — | ||
| Q1 25 | $0.64 | — | ||
| Q4 24 | $0.68 | — | ||
| Q3 24 | $0.69 | — | ||
| Q2 24 | $0.68 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $198.4M | $90.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.3B | $341.7M |
| 总资产 | $9.9B | $461.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BYCTKB
| Q1 26 | $198.4M | — | ||
| Q4 25 | $149.1M | $90.9M | ||
| Q3 25 | $259.0M | $93.3M | ||
| Q2 25 | $218.3M | $75.5M | ||
| Q1 25 | $421.3M | $95.3M | ||
| Q4 24 | $563.1M | $98.7M | ||
| Q3 24 | $452.6M | $162.3M | ||
| Q2 24 | $730.5M | $177.9M |
股东权益BYCTKB
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $341.7M | ||
| Q3 25 | $1.2B | $378.6M | ||
| Q2 25 | $1.2B | $377.6M | ||
| Q1 25 | $1.1B | $379.6M | ||
| Q4 24 | $1.1B | $395.7M | ||
| Q3 24 | $1.1B | $385.5M | ||
| Q2 24 | $1.0B | $389.1M |
总资产BYCTKB
| Q1 26 | $9.9B | — | ||
| Q4 25 | $9.7B | $461.5M | ||
| Q3 25 | $9.8B | $494.9M | ||
| Q2 25 | $9.7B | $493.3M | ||
| Q1 25 | $9.6B | $482.6M | ||
| Q4 24 | $9.5B | $499.5M | ||
| Q3 24 | $9.4B | $491.2M | ||
| Q2 24 | $9.6B | $483.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-771.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-1.8M |
| 自由现金流率自由现金流/营收 | — | -2.9% |
| 资本支出强度资本支出/营收 | — | 1.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-8.8M |
8季度趋势，按日历期对齐
经营现金流BYCTKB
| Q1 26 | — | — | ||
| Q4 25 | $140.3M | $-771.0K | ||
| Q3 25 | $38.3M | $-3.9M | ||
| Q2 25 | $16.3M | $108.0K | ||
| Q1 25 | $27.1M | $-125.0K | ||
| Q4 24 | $175.2M | $2.0M | ||
| Q3 24 | $19.8M | $13.2M | ||
| Q2 24 | $40.1M | $6.2M |
自由现金流BYCTKB
| Q1 26 | — | — | ||
| Q4 25 | $136.3M | $-1.8M | ||
| Q3 25 | $38.0M | $-4.6M | ||
| Q2 25 | $15.2M | $-1.5M | ||
| Q1 25 | $25.0M | $-974.0K | ||
| Q4 24 | $171.2M | $1.1M | ||
| Q3 24 | $19.1M | $12.2M | ||
| Q2 24 | $39.4M | $5.2M |
自由现金流率BYCTKB
| Q1 26 | — | — | ||
| Q4 25 | 116.5% | -2.9% | ||
| Q3 25 | 32.8% | -8.7% | ||
| Q2 25 | 13.7% | -3.2% | ||
| Q1 25 | 24.3% | -2.3% | ||
| Q4 24 | 163.5% | 1.9% | ||
| Q3 24 | 18.8% | 23.7% | ||
| Q2 24 | 39.7% | 11.0% |
资本支出强度BYCTKB
| Q1 26 | — | — | ||
| Q4 25 | 3.4% | 1.6% | ||
| Q3 25 | 0.3% | 1.3% | ||
| Q2 25 | 1.0% | 3.5% | ||
| Q1 25 | 2.0% | 2.0% | ||
| Q4 24 | 3.8% | 1.6% | ||
| Q3 24 | 0.6% | 2.0% | ||
| Q2 24 | 0.7% | 2.3% |
现金转化率BYCTKB
| Q1 26 | — | — | ||
| Q4 25 | 4.06× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 0.54× | — | ||
| Q1 25 | 0.96× | — | ||
| Q4 24 | 5.78× | 0.21× | ||
| Q3 24 | 0.65× | 14.05× | ||
| Q2 24 | 1.35× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BY
暂无分部数据
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
